Definitive Healthcare Corp. (NASDAQ:DH) Stock Has Average Price Target of $1.47

Shares of Definitive Healthcare Corp. (NASDAQ:DH) have been assigned a consensus rating of “Reduce” from the nine analysts that are presently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation and six have assigned a hold recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $1.47.

Several analysts have weighed in on the company. Morgan Stanley dropped their price target on Definitive Healthcare from $2.50 to $1.50 and set an “equal weight” rating on the stock in a research note on Tuesday, August 11th. BTIG Research reissued a “neutral” rating on shares of Definitive Healthcare in a research note on Friday, September 4th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $1.00 price target on shares of Definitive Healthcare in a research note on Wednesday, August 12th. Wall Street Zen raised shares of Definitive Healthcare from a “hold” rating to a “buy” rating in a report on Sunday, September 13th. Finally, Weiss Ratings upgraded shares of Definitive Healthcare from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday.

Definitive Healthcare Stock Performance

Definitive Healthcare stock opened at $1.15 on Wednesday. Definitive Healthcare has a fifty-two week low of $0.61 and a fifty-two week high of $3.00. The company has a market cap of $122.76 million, a P/E ratio of 28.25, a price-to-earnings-growth ratio of 13.94 and a beta of 1.40. The firm’s 50 day simple moving average is $1.02 and its 200-day simple moving average is $1.06. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.86 and a quick ratio of 1.86.

Definitive Healthcare (NASDAQ:DH) last posted its earnings results on Thursday, November 5th. The company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. Definitive Healthcare had a positive return on equity of 3.55% and a negative net margin of 72.28%. The company had revenue of $54.65 million during the quarter, compared to the consensus estimate of $54.58 million. As a group, equities research analysts predict that Definitive Healthcare will post 0.06 EPS for the current year.

Hedge Funds Weigh In On Definitive Healthcare

Large investors have recently made changes to their positions in the business. Williams & Novak LLC raised its holdings in shares of Definitive Healthcare by 155.8% in the 2nd quarter. Williams & Novak LLC now owns 78,610 shares of the company’s stock valued at $65,000 after purchasing an additional 47,880 shares in the last quarter. Irenic Capital Management LP acquired a new position in Definitive Healthcare in the 1st quarter worth approximately $71,000. Williams & Novak Wealth Management LLC raised its stake in shares of Definitive Healthcare by 15.3% in the 3rd quarter. Williams & Novak Wealth Management LLC now owns 90,610 shares of the company’s stock valued at $82,000 after acquiring an additional 12,000 shares in the last quarter. Jefferies Financial Group Inc. acquired a new position in shares of Definitive Healthcare in the 3rd quarter valued at $90,000. Finally, Squarepoint Ops LLC lifted its holdings in Definitive Healthcare by 46.5% during the 2nd quarter. Squarepoint Ops LLC now owns 351,575 shares of the company’s stock worth $292,000 after buying an additional 111,634 shares in the last quarter. Institutional investors and hedge funds own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp. (NASDAQ: DH) provides data, analytics and commercial intelligence solutions for the healthcare industry. Its platform is designed to help organizations understand healthcare markets, identify business opportunities and make data-driven decisions.

The company serves pharmaceutical and biotechnology companies, medical device manufacturers, healthcare providers, hospitals and health systems, and other healthcare services organizations. Its offerings include information on healthcare providers and organizations, market intelligence, sales and marketing analytics, clinical trial insights, and tools that support commercial planning, market access and customer engagement.

Definitive Healthcare was founded in 2011 and became a publicly traded company in 2021.